Acumen Pharmaceuticals, Inc. (ABOS) KPIs and segments

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30

$0.21−0.00 (-1.83%)

Close on Nov 13, 2026Market cap $15.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Acumen Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Acumen Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?